ArticleExperimental and therapeutic medicine2022

Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma.

Aram A Musaelyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.